Overcoming Immunotherapy Resistance Mechanisms in Kidney Cancer
Current research initiatives in the kidney cancer field include exploring anti–PD-1, anti–LAG-3, and anti–CTLA-4 combination regimens.
Advertisement
300x250 Banner
Pulmonology • 2 hours ago
Cardiology • 4 hours ago
Rheumatology • 6 hours ago